Rezolute Inc (RZLT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $346.29M
Last updated: Nov 17, 2026 at 4:43 PM ET
Rezolute Inc (RZLT) Statistics
Rezolute (RZLT) has a market cap of $346.29M and an enterprise value of $338.14M. It has 104.78M shares outstanding.
Total Valuation
Enterprise value is 2.35% below the market cap, as cash exceeds debt.
| Market Cap | $346.29M |
|---|---|
| Enterprise Value | $338.14M |
| Latest price (Nov 17, 2026) | $4.01 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | June |
Valuation Ratios
| Forward P/S | 150.3x |
|---|---|
| P/B Ratio | 4.9x |
Price Statistics
The stock is down 59.32% over 52 weeks and trades 0.74% below its 50-day average.
| Beta (1Y) | 1.11 |
|---|---|
| 52-Week Change | -59.32% |
| 1-Month Change | +8.51% |
| 3-Month Change | -14.94% |
| 6-Month Change | +29.52% |
| 5-Year Change | -38.28% |
| 10-Year Change | -93.42% |
| Total Return (1Y) | -59.32% |
| Total Return (5Y CAGR) | -7.79% |
| Return vs SPY (1Y) | -72.04% |
| Max Drawdown (1Y) | -87.20% |
| Max Drawdown (3Y) | -87.20% |
| Sharpe Ratio (1Y) | -0.41 |
| Correlation with SPY (1Y) | 0.07 |
| 50-Day Average | $4.04 |
| 200-Day Average | $3.93 |
| 52-Week Range | $1.07 to $11.16 |
| RSI (14 Days) | 51.4 |
| Average Volume (20 Days) | 1.69M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 9.92x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 9.92x |
|---|---|
| Quick Ratio | 9.92x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -90.66% over the last 12 months, against a 5-year average of -50.32%.
| Return on Equity (ROE) | -90.66% |
|---|---|
| Return on Assets (ROA) | -81.16% |
| ROE (5Y Average) | -50.32% |
| ROA (5Y Average) | -46.31% |
| ROIC (5Y Average) | -41.97% |
Scores
RZLT has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
| Operating Income | -$82.53M |
|---|---|
| Pretax Income | -$77.92M |
| Net Income | -$77.92M |
| Reported EPS (TTM) | -$0.76 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 89.52% of the $96.01M in total assets.
| Cash and Equivalents | $8.15M |
|---|---|
| Total Debt | $0 |
| Net Cash | $8.15M |
| Net Cash Per Share | $0.08 |
| Working Capital | $84.37M |
| Shareholder Equity | $85.95M |
| Book Value Per Share | $0.82 |
| Total Assets | $96.01M |
| Total Liabilities | $10.06M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$65.99M |
|---|---|
| FCF Per Share | -$0.68 |
| Depreciation and Amortization | $2.16M |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
RZLT does not pay a dividend.
| Buyback Yield | 0.00% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-50 reverse split on Oct 13, 2020.
| Last Split Date | Oct 13, 2020 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:50 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About RZLT
What is RZLT's market cap?
Rezolute has a market cap of $346.29M. Its enterprise value, which adds debt and subtracts cash, is $338.14M.
How many shares of RZLT are outstanding?
Rezolute has 104.78M shares outstanding. The count is up 1.31% from a year earlier.
Does RZLT pay a dividend?
No. Rezolute does not pay a dividend.
How much debt does RZLT have?
Rezolute has $0 of total debt and $8.15M of cash and equivalents, a net cash position of $8.15M.
RZLT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors